Envista Holdings Corporation (NYSE:NVST) Receives $27.75 Consensus PT from Brokerages
by Scott Moore · The Cerbat GemEnvista Holdings Corporation (NYSE:NVST – Get Free Report) has been given a consensus rating of “Moderate Buy” by the fifteen brokerages that are presently covering the firm, Marketbeat Ratings reports. Seven investment analysts have rated the stock with a hold recommendation, seven have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $27.75.
A number of brokerages recently weighed in on NVST. JPMorgan Chase & Co. boosted their price objective on shares of Envista from $22.00 to $26.00 and gave the company a “neutral” rating in a research report on Friday, February 6th. Leerink Partners set a $35.00 target price on Envista and gave the company an “outperform” rating in a research note on Friday, February 6th. William Blair raised Envista from a “hold” rating to an “outperform” rating in a report on Friday, February 6th. Piper Sandler reiterated a “neutral” rating and set a $25.00 price target (up from $21.00) on shares of Envista in a research report on Friday, February 6th. Finally, UBS Group raised their price target on Envista from $22.00 to $25.00 and gave the stock a “neutral” rating in a report on Tuesday, February 3rd.
Get Our Latest Research Report on Envista
Envista Stock Performance
Envista stock opened at $24.60 on Wednesday. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.38 and a quick ratio of 2.04. Envista has a 12 month low of $14.22 and a 12 month high of $30.42. The company has a fifty day moving average price of $26.56 and a two-hundred day moving average price of $22.89. The company has a market cap of $4.03 billion, a PE ratio of 87.86, a P/E/G ratio of 1.76 and a beta of 0.95.
Envista (NYSE:NVST – Get Free Report) last issued its earnings results on Thursday, February 5th. The company reported $0.38 earnings per share for the quarter, topping analysts’ consensus estimates of $0.32 by $0.06. Envista had a net margin of 1.73% and a return on equity of 6.54%. During the same quarter in the previous year, the business earned $0.24 EPS. The firm’s quarterly revenue was up 15.0% compared to the same quarter last year. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Research analysts expect that Envista will post 1 earnings per share for the current year.
Insider Buying and Selling
In related news, SVP Mischa Reis sold 9,675 shares of the company’s stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $30.00, for a total transaction of $290,250.00. Following the completion of the transaction, the senior vice president directly owned 32,382 shares in the company, valued at $971,460. This represents a 23.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.66% of the stock is currently owned by insiders.
Hedge Funds Weigh In On Envista
Institutional investors have recently modified their holdings of the company. Farther Finance Advisors LLC lifted its position in Envista by 317.6% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock valued at $27,000 after purchasing an additional 1,026 shares during the last quarter. Caitong International Asset Management Co. Ltd grew its position in Envista by 16,711.1% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock worth $31,000 after purchasing an additional 1,504 shares during the last quarter. Allworth Financial LP increased its stake in shares of Envista by 75.4% in the fourth quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after purchasing an additional 776 shares during the period. UMB Bank n.a. raised its holdings in shares of Envista by 46.1% during the fourth quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock valued at $44,000 after buying an additional 636 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Envista by 73.1% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock valued at $44,000 after buying an additional 949 shares during the last quarter.
Envista Company Profile
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.